WOMEN'S HEALTHComplementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach
REFERENCES (70)
- et al.
Use of alternative and complementary medicine in menopause
Int J Gynaecol Obstet
(2002) - et al.
Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy
Maturitas
(1999) - et al.
Use of alternative therapies for menopause symptoms: results of a population-based survey
Obstet Gynecol
(2002) - et al.
Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy
Maturitas
(2004) The acute effects of exercise on mood state
J Psychosom Res
(1996)- et al.
Behavioural treatment of hot flushes: evaluation by ambulatory monitoring
Am J Obstet Gynecol
(1992) - et al.
Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo
Maturitas
(2002) - et al.
Soy for the treatment of perimenopausal symptoms – a systematic review
Maturitas
(2004) - et al.
Dietary soy supplementation and phytoestrogen levels
Obstet Gynecol
(1999) - et al.
Benefits of soy isoflavone therapeutic regimen on menopausal symptoms
Obstet Gynecol
(2002)
A 2-year soy intervention in premenopausal women does not change mammographic densities
J Nutr
(2004)
Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study
Fertil Steril
(2004)
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers
Maturitas
(2003)
Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society
Menopause
(2004)
Health care-seeking for menopausal problems
Climacteric
(2003)
National use of postmenopausal hormone therapy
JAMA
(2004)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled tria
JAMA
(2002)
Cardiovascular disease outcomes during 6.8 years of hormone therapy
JAMA
(2002)
Guidelines for hormone treatment of women in the menopausal transition and beyond. Position Statement by the Executive Committee of the International Menopause Society
Climacteric
(2004)
Changes in the use of hormone replacement therapy in New Zealand following the publication of the Women’s Health Initiative trial
NZ Med J
(2004)
Patients’ and clinicians’ attitudes after the Women’s Health Initiative study
Menopause
(2004)
Practical recommendations for hormone replacement therapy in the peri- and postmenopause
Climacteric
(2004)
The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women
J Obstet Gynaecol Can
(2002)
Position Statement by the Executive Committee of the International Menopause Society. Guidelines for the hormone treatment of women in the menopausal transition and beyond
Climacteric
(2004)
Managing the menopause
Consensus statement on hormone replacement therapy. June
(2004)
Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey
Menopause
(1998)
The use of complementary and alternative medications by menopausal women in South East Queensland
Women’s Health Issues
(2004)
Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies
Menopause
(2003)
Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic
Climacteric
(2001)
Dietary supplement use among menopausal women attending a San Francisco health conference
Menopause
(2002)
The effects of relaxation response training on menopausal symptoms
J Psychosom Obstet Gynaecol
(1996)
Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extract for large scale use in hormone replacement therapy
J Steroid Biochem Mol Biol
(1831)
Cited by (25)
Hormone Therapy for Menopausal Women in the Primary Care Setting
2017, Journal for Nurse PractitionersCitation Excerpt :This leaves menopausal women susceptible to dyspareunia and atrophic vaginal mucosa and puts them at an increased risk for urinary tract infections.4,12 VMSs, particularly hot flashes, are the most common reasons that women seek care during the perimenopausal and menopausal period, along with urovaginal symptoms.3,8 The North American Menopause Society (NAMS) recommends lifestyle changes, such as regular exercise and regulation of body temperature through the layering of clothing and the use of external heating/cooling systems, as the initial step for the management of VMS, whereas suggestions for nonprescription options include the use of vitamin E, soy, and black cohosh.3,4,7
A systematic analysis of vascular paroxysm pathophysiology in perimenopause: Methods for nutritional correction
2020, Obstetrics, Gynecology and ReproductionManaging hot flushes in menopausal women: A review
2018, Journal of the College of Physicians and Surgeons PakistanHormone therapy for relieving postmenopausal vasomotor symptoms: A systematic review
2016, Archives of Iranian Medicine
Competing Interests: See Acknowledgements.
Copyright © 2006 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.